Zenith® AAA Endovascular Graft Clinical Study
Not Applicable
Completed
- Conditions
- Abdominal Aortic Aneurysm
- Interventions
- Device: High RiskDevice: Treatment for femalesDevice: Roll-inDevice: SurgicalDevice: Standard RiskDevice: Compassionate UseDevice: Standard Risk Continued AccessDevice: High Risk Continued Access
- Registration Number
- NCT00196092
- Lead Sponsor
- Cook Group Incorporated
- Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of the Cook Zenith Endovascular Graft for the treatment of abdominal aortic (AAA), aortoiliac, and iliac aneurysms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 819
Inclusion Criteria
- Patients with an aortic or aortoiliac aneurysm with diameter greater than or equal to 4 cm.
- Patients with an iliac aneurysm with diameter greater than or equal to 3.5 cm.
- Patients with an aortic, aortoiliac, or iliac aneurysm with a history of growth greater than or equal to 0.5 cm per year.
Exclusion Criteria
- Patients less than 18 years of age.
- Patient with a life expectancy less than 2 years.
- Patients who are pregnant.
- Patients unwilling to comply with the follow-up schedule.
- Patient inability or refusal to give informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 4 High Risk High Risk 6 Treatment for females Treatment for females. 1 Roll-in Roll-in 2 Surgical Surgical 3 Standard Risk Standard Risk 5 Compassionate Use Compassionate Use 7 Standard Risk Continued Access Standard Risk Continued Access 8 High Risk Continued Access High Risk Continued Access
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method